GlassScriptPhysician profile
Markus A Giacomuzzi
NPI 1720072978
$2,506.79
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,087 · 2020: $569 · 2021: $744 · 2022: $48.22 · 2023: $58.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $58.76.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $58.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $737.55 | 2019 | |
| Medline Industries LP | $644.78 | 2019-2021 | |
| Crossroads Extremity Systems, LLC | $249.66 | 2020 | |
| Bone Support INC. | $158.00 | 2021 | |
| Tactile Systems Technology INC | $134.58 | 2019-2023 | Entre Plus, Flexitouch Plus |
| Smith+Nephew, INC. | $125.96 | 2020 | |
| Wright Medical Technology, INC. | $98.24 | 2019 | |
| Horizon Therapeutics Plc | $95.61 | 2019-2021 | |
| Stryker Corporation | $91.95 | 2019 | |
| Pfizer INC. | $48.36 | 2019-2020 | |
| Abbott Laboratories | $45.40 | 2023 | Prodigy, Eterna |
| Orthofix Medical, INC. | $37.77 | 2019 | |
| Medinc of Texas | $20.89 | 2022 | |
| Kci USA, INC. | $18.04 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Markus Giacomuzzi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.